California Public Employees Retirement System’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-9,376
Closed -$273K 1223
2022
Q2
$273K Buy
9,376
+3,531
+60% +$158K ﹤0.01% 1217
2022
Q1
$543K Sell
5,845
-372
-6% -$32.3K ﹤0.01% 1220
2021
Q4
$593K Buy
6,217
+122
+2% +$16.7K ﹤0.01% 1232
2021
Q3
$1.09M Buy
+6,095
New +$1.35M ﹤0.01% 1231

Other funds holding BNR

California Public Employees Retirement System's BNR Position: Q3 2022 in Review

California Public Employees Retirement System sold out of Burning Rock Biotech (BNR) in Q3 2022, closing a stake of 9,376 shares — an estimated $273K sold.

California Public Employees Retirement System first reported a position in BNR in Q3 2021 and held it in 4 quarters. The position peaked at $1.09M in Q3 2021. 52 funds tracked by Wall St. Rank hold BNR as of Q3 2022.

  • California Public Employees Retirement System reported no remaining Burning Rock Biotech position as of Q3 2022 after selling out during the quarter.
  • California Public Employees Retirement System sold 9,376 Burning Rock Biotech shares in Q3 2022, an estimated $273K.
  • California Public Employees Retirement System first reported a position in Burning Rock Biotech in Q3 2021 and held it in 4 quarters.
  • California Public Employees Retirement System's Burning Rock Biotech position peaked at $1.09M in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2022.

Based on California Public Employees Retirement System's 13F filing for Q3 2022, filed 9 Nov 2022.